580 related articles for article (PubMed ID: 34710063)
1. The intersection of COVID-19 and autoimmunity.
Knight JS; Caricchio R; Casanova JL; Combes AJ; Diamond B; Fox SE; Hanauer DA; James JA; Kanthi Y; Ladd V; Mehta P; Ring AM; Sanz I; Selmi C; Tracy RP; Utz PJ; Wagner CA; Wang JY; McCune WJ
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34710063
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
3. Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity.
Opdenakker G; Van Damme J
Cytokine Growth Factor Rev; 2021 Apr; 58():134-140. PubMed ID: 33563543
[TBL] [Abstract][Full Text] [Related]
4. The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals.
Cañas CA
Med Hypotheses; 2020 Dec; 145():110345. PubMed ID: 33080459
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
Baiocchi GC; Vojdani A; Rosenberg AZ; Vojdani E; Halpert G; Ostrinski Y; Zyskind I; Filgueiras IS; Schimke LF; Marques AHC; Giil LM; Lavi YB; Silverberg JI; Zimmerman J; Hill DA; Thornton A; Kim M; De Vito R; Fonseca DLM; Plaça DR; Freire PP; Camara NOS; Calich VLG; Scheibenbogen C; Heidecke H; Lattin MT; Ochs HD; Riemekasten G; Amital H; Shoenfeld Y; Cabral-Marques O
J Med Virol; 2023 Feb; 95(2):e28538. PubMed ID: 36722456
[TBL] [Abstract][Full Text] [Related]
6. Partners in crime: Autoantibodies complicit in COVID-19 pathogenesis.
Taghadosi M; Safarzadeh E; Asgarzadeh A; Roghani SA; Shamsi A; Jalili C; Assar S; Soufivand P; Pournazari M; Feizollahi P; Nicknam MH; Asghariazar V; Vaziri S; Shahriari H; Mohammadi A
Rev Med Virol; 2023 Mar; 33(2):e2412. PubMed ID: 36471421
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 triggering autoimmune diseases.
Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
[TBL] [Abstract][Full Text] [Related]
8. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune complications of COVID-19.
Yazdanpanah N; Rezaei N
J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
[TBL] [Abstract][Full Text] [Related]
10. [SARS-CoV-2 infection and autoimmunity].
Meyer-Bahlburg A
Z Rheumatol; 2024 Feb; 83(1):34-40. PubMed ID: 38108865
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and autoimmune diseases.
Liu Y; Sawalha AH; Lu Q
Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 infection: a possible induction factor for development of autoimmune diseases?
Saeedi N; Gohari NSF; Ghalibaf AAM; Dehghan A; Owlia MB
Immunol Res; 2023 Aug; 71(4):547-553. PubMed ID: 37316687
[TBL] [Abstract][Full Text] [Related]
13. Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection.
Chen C; Amelia A; Ashdown GW; Mueller I; Coussens AK; Eriksson EM
Mol Med; 2021 Dec; 27(1):160. PubMed ID: 34930107
[TBL] [Abstract][Full Text] [Related]
14. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
Mohkhedkar M; Venigalla SSK; Janakiraman V
Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
[TBL] [Abstract][Full Text] [Related]
15. COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Fatone MC
Curr Rheumatol Rev; 2021; 17(1):7-16. PubMed ID: 33019935
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells.
Castleman MJ; Stumpf MM; Therrien NR; Smith MJ; Lesteberg KE; Palmer BE; Maloney JP; Janssen WJ; Mould KJ; Beckham JD; Pelanda R; Torres RM
Front Immunol; 2022; 13():988125. PubMed ID: 36131937
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated naive B cells and de novo autoreactivity in severe COVID-19.
Woodruff MC; Ramonell RP; Haddad NS; Anam FA; Rudolph ME; Walker TA; Truong AD; Dixit AN; Han JE; Cabrera-Mora M; Runnstrom MC; Bugrovsky R; Hom J; Connolly EC; Albizua I; Javia V; Cashman KS; Nguyen DC; Kyu S; Singh Saini A; Piazza M; Tipton CM; Khosroshahi A; Gibson G; Martin GS; Maier CL; Esper A; Jenks SA; Lee FE; Sanz I
Nature; 2022 Nov; 611(7934):139-147. PubMed ID: 36044993
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity.
Jaycox JR; Lucas C; Yildirim I; Dai Y; Wang EY; Monteiro V; Lord S; Carlin J; Kita M; Buckner JH; Ma S; Campbell M; Ko A; Omer S; Lucas CL; Speake C; Iwasaki A; Ring AM
Nat Commun; 2023 Mar; 14(1):1299. PubMed ID: 36894554
[TBL] [Abstract][Full Text] [Related]
19. Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.
Acosta-Ampudia Y; Monsalve DM; Rojas M; Rodríguez Y; Zapata E; Ramírez-Santana C; Anaya JM
J Infect Dis; 2022 Jun; 225(12):2155-2162. PubMed ID: 35079804
[TBL] [Abstract][Full Text] [Related]
20. COVID-19: A trigger of autoimmune diseases.
Zebardast A; Hasanzadeh A; Ebrahimian Shiadeh SA; Tourani M; Yahyapour Y
Cell Biol Int; 2023 May; 47(5):848-858. PubMed ID: 36740221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
